Journal
CARCINOGENESIS
Volume 31, Issue 6, Pages 1092-1099Publisher
OXFORD UNIV PRESS
DOI: 10.1093/carcin/bgq040
Keywords
-
Categories
Funding
- Korea government (Ministry of Education, Science and Technology) [R01-2008-000-20131-0]
Ask authors/readers for more resources
Activation of the mammalian target of rapamycin (mTOR) pathway promotes tumorigenesis, and inhibiting the mammalian target of rapamycin complex 1 (mTORC1) has emerged as an attractive target for suppressing tumor growth. We found that selenium treatment of HT-29 colon cancer cells suppressed mTORC1 through Akt-independent and -dependent pathways. In Akt-independent mTORC1 inhibition in selenium-treated colon cancer cells, adenosine monophosphate-activated protein kinase (AMPK) alpha(1) was crucial for suppression of mTORC1 activity. In contrast, the Akt-dependent mTORC1 inhibition by selenium did not require AMPK alpha(1). The importance of the AMPK alpha(1)-mTORC1 pathway in mediating the antiproliferative action of selenium was examined in xenograft tumors, and the suppression of mTORC1 as well as Akt was concomitant with an increase in AMPK alpha(1) activity. These findings suggest that the antiproliferative effect of selenium is mediated by an Akt-independent AMPK alpha(1)/mTORC1 pathway or by the Akt/tuberous sclerosis complex 2 /mTORC1 pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available